JP2016500073A5 - - Google Patents

Download PDF

Info

Publication number
JP2016500073A5
JP2016500073A5 JP2015543098A JP2015543098A JP2016500073A5 JP 2016500073 A5 JP2016500073 A5 JP 2016500073A5 JP 2015543098 A JP2015543098 A JP 2015543098A JP 2015543098 A JP2015543098 A JP 2015543098A JP 2016500073 A5 JP2016500073 A5 JP 2016500073A5
Authority
JP
Japan
Prior art keywords
carboxamide
pyrazine
methyl
imidazo
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015543098A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016500073A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/070623 external-priority patent/WO2014078813A1/en
Publication of JP2016500073A publication Critical patent/JP2016500073A/ja
Publication of JP2016500073A5 publication Critical patent/JP2016500073A5/ja
Pending legal-status Critical Current

Links

JP2015543098A 2012-11-19 2013-11-18 寄生虫病の処置のための化合物および組成物 Pending JP2016500073A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261728024P 2012-11-19 2012-11-19
US61/728,024 2012-11-19
PCT/US2013/070623 WO2014078813A1 (en) 2012-11-19 2013-11-18 Compounds and compositions for the treatment of parasitic diseases

Publications (2)

Publication Number Publication Date
JP2016500073A JP2016500073A (ja) 2016-01-07
JP2016500073A5 true JP2016500073A5 (enExample) 2016-12-28

Family

ID=49667633

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015543098A Pending JP2016500073A (ja) 2012-11-19 2013-11-18 寄生虫病の処置のための化合物および組成物

Country Status (5)

Country Link
US (1) US20150291598A1 (enExample)
EP (1) EP2920177A1 (enExample)
JP (1) JP2016500073A (enExample)
CN (1) CN105189506A (enExample)
WO (1) WO2014078813A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105189506A (zh) * 2012-11-19 2015-12-23 诺华股份有限公司 用于治疗寄生虫疾病的化合物和组合物
WO2014078802A1 (en) 2012-11-19 2014-05-22 Irm Llc Compounds and compositions for the treatment of parasitic diseases
CA2952895C (en) * 2014-06-25 2023-09-26 F. Hoffmann-La Roche Ag Imidazo[1,2-a]pyrazin-1yl-benzamide compounds for treating spinal muscular atrophy
EA032416B1 (ru) 2014-12-23 2019-05-31 Новартис Аг Соединения триазолопиримидина и их применения
CN104610229B (zh) * 2015-01-21 2017-01-18 上海皓元生物医药科技有限公司 一种是atp竞争性小分子akt抑制剂a443654的合成方法
EP3472168B1 (en) 2016-06-20 2024-01-10 Novartis AG Crystalline forms of triazolopyrimidine compound
US10676479B2 (en) 2016-06-20 2020-06-09 Novartis Ag Imidazolepyridine compounds and uses thereof
WO2017221092A1 (en) 2016-06-20 2017-12-28 Novartis Ag Triazolopyridine compounds and uses thereof
GB201700692D0 (en) * 2017-01-16 2017-03-01 Salvensis Novel compounds and their use in the treatment of schistosomiasis
JP6818131B2 (ja) * 2017-04-27 2021-01-20 日本農薬株式会社 縮合複素環化合物又はその塩類、及びそれらの化合物を含有する農園芸用殺虫剤並びにその使用方法
WO2018237349A1 (en) * 2017-06-23 2018-12-27 University Of Washington Inhibitors of typed 1 methionyl-trna synthetase and methods of using them
KR20200022027A (ko) * 2017-06-30 2020-03-02 리부 세라퓨틱스 에스.에이. 아데노신 A2A 수용체의 이미다조[1,2,a]피라진 조절물질
WO2019051642A1 (zh) * 2017-09-12 2019-03-21 广州中科蓝华生物科技有限公司 一种转染细胞内寄生虫的试剂盒及其应用
KR20200115620A (ko) 2018-01-29 2020-10-07 메르크 파텐트 게엠베하 Gcn2 억제제 및 이의 용도
WO2019245590A1 (en) 2018-06-18 2019-12-26 Avista Pharma Solutions, Inc. Chemical compounds
GB201811695D0 (en) 2018-07-17 2018-08-29 Salvensis Compounds for use in the treatment of fascioliasis
CA3104054A1 (en) 2018-08-21 2020-02-27 Kyorin Pharmaceutical Co., Ltd. Bicyclic heteroaromatic ring derivative
BR112021007421A2 (pt) 2018-12-06 2021-08-03 Daiichi Sankyo Company, Limited derivado de cicloalcano-1,3-diamina
EP3917932A4 (en) 2019-01-30 2022-09-28 Avista Pharma Solutions, Inc. CHEMICAL COMPOUNDS
CA3128346A1 (en) 2019-01-30 2020-08-06 Avista Pharma Solutions, Inc. Synthetic process and novel intermediates
BR112022007404A2 (pt) * 2019-10-21 2022-07-05 Novartis Ag Compostos e composições para o tratamento de doenças parasíticas
WO2024022910A1 (en) 2022-07-26 2024-02-01 Syngenta Crop Protection Ag 1-[1-[2-(pyrimidin-4-yl)-1,2,4-triazol-3-yl]ethyl]-3-[2,4-dichloro-5-phenyl]urea derivatives and similar compounds as pesticides
EP4695245A1 (en) * 2023-04-13 2026-02-18 Syngenta Crop Protection AG Imidazo[1,2-a]pyridine derivatives
TW202446263A (zh) * 2023-04-13 2024-12-01 瑞士商先正達農作物保護股份公司 殺真菌組成物
EP4695246A1 (en) * 2023-04-13 2026-02-18 Syngenta Crop Protection AG Imidazo[1,2-a]pyridine derivatives
PY2426847A (es) * 2023-04-13 2025-03-20 Syngenta Crop Prot Ag Derivados bicíclicos de imidazo
AR132352A1 (es) * 2023-04-13 2025-06-18 Syngenta Crop Protection Ag Derivados de imidazo[1,2-a]pirazina
CN120957990A (zh) * 2023-04-13 2025-11-14 先正达农作物保护股份公司 咪唑并[1,2-a]吡啶衍生物
WO2026018203A1 (en) * 2024-07-19 2026-01-22 Novartis Ag Aminoisoquinoline compounds and methods of using thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2514733A1 (en) 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
EP2124954A2 (en) * 2007-01-26 2009-12-02 Irm Llc Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseases
TWI421252B (zh) * 2009-07-09 2014-01-01 Irm Llc 用於治療寄生蟲疾病之化合物及組合物
CN105189506A (zh) * 2012-11-19 2015-12-23 诺华股份有限公司 用于治疗寄生虫疾病的化合物和组合物

Similar Documents

Publication Publication Date Title
JP2016500073A5 (enExample)
US11591336B2 (en) Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors
ES2968796T3 (es) Derivados de tiadiazolilo como inhibidores de la ADN polimerasa theta
JP5864589B2 (ja) 細菌トポイソメラーゼii阻害性2−エチルカルバモイルアミノ−1,3−ベンゾチアゾール−5−イル類
JP2015522002A5 (enExample)
JP2017530960A5 (enExample)
RU2017105296A (ru) Новые соединения
JP2013508404A5 (enExample)
JP2020527560A5 (enExample)
JP2020514267A5 (enExample)
HRP20201469T1 (hr) Derivati tetrahidroizokinolina
JP2017510576A5 (enExample)
RU2016124178A (ru) Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
JP2017520607A (ja) 置換尿素誘導体及びその薬学的使用
JP2016500073A (ja) 寄生虫病の処置のための化合物および組成物
JP2016519096A5 (enExample)
CN111868037B (zh) 作为crhr2拮抗剂的稠合环状脲衍生物
JP2016507551A5 (enExample)
JP2014511355A5 (enExample)
WO2017102091A1 (en) Heteroarylbenzimidazole compounds
IL310330A (en) Compounds for the treatment of pain, in particular neuropathic pain, and/or other diseases or disorders that are associated with at2r and/or at2r mediated signaling
US20250230155A1 (en) 7,8-dihydro-5h-1,6-naphthyridine derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4 for treating neurological and psychiatric disorders
JPWO2020052631A5 (enExample)
AU2023305453A1 (en) Tyrosine kinase 2 inhibitors and uses thereof
JPWO2019198692A5 (enExample)